Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Hilton Grand Vacations
HGV
$3.59B
| $922K | ﹤0.01% |
27,866
-36,902
| -57% | -$1.23M |
|
3652
CALL
ProShares UltraPro Short QQQ
SQQQ
$1.7B
| $920K | ﹤0.01% |
33
-2
| -6% | -$61.1K |
|
3653
CALL
LendingTree
TREE
$457M
| $920K | ﹤0.01% |
4,000
+3,000
| +300% | +$713K |
|
3654
CALL
Yelp
YELP
$1.33B
| $920K | ﹤0.01% |
18,700
-94,000
| -83% | -$4.11M |
|
|
THR
3655
DELISTED
Thermon Group Holdings
THR
| $917K | ﹤0.01% |
35,593
+10,921
| +44% | +$275K |
|
|
SINA
3656
CALL
DELISTED
Sina Corp
SINA
| $917K | ﹤0.01% |
13,200
-3,900
| -23% | -$292K |
|
3657
Opko Health
OPK
$993M
| $916K | ﹤0.01% |
264,642
+42,018
| +19% | +$223K |
|
3658
PUT
Waters Corp
WAT
$40.4B
| $915K | ﹤0.01% |
4,700
+4,100
| +683% | +$794K |
|
|
GLUU
3659
DELISTED
Glu Mobile Inc.
GLUU
| $914K | ﹤0.01% |
122,662
+28,699
| +31% | +$193K |
|
|
NVTR
3660
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $914K | ﹤0.01% |
41,557
+40,537
| +3,974% | +$780K |
|
|
RDUS
3661
PUT
DELISTED
Radius Health, Inc.
RDUS
| $913K | ﹤0.01% |
51,300
+23,600
| +85% | +$534K |
|
3662
PUT
Intuit
INTU
$94.7B
| $910K | ﹤0.01% |
4,000
-1,700
| -30% | -$365K |
|
|
RAD
3663
DELISTED
Rite Aid Corporation
RAD
| $909K | ﹤0.01% |
35,534
-30,828
| -46% | -$949K |
|
|
CDR
3664
DELISTED
Cedar Realty Trust, Inc
CDR
| $909K | ﹤0.01% |
29,569
+14,445
| +96% | +$444K |
|
3665
Travere Therapeutics
TVTX
$5.8B
| $908K | ﹤0.01% |
31,620
+23,585
| +294% | +$674K |
|
|
DO
3666
CALL
DELISTED
Diamond Offshore Drilling
DO
| $908K | ﹤0.01% |
45,400
-15,600
| -26% | -$287K |
|
|
AHRT
3667
AH Realty Trust
AHRT
$506M
| $907K | ﹤0.01% |
59,982
+34,751
| +138% | +$534K |
|
|
FL
3668
CALL
DELISTED
Foot Locker
FL
| $907K | ﹤0.01% |
17,800
-26,800
| -60% | -$1.33M |
|
|
RVI
3669
DELISTED
Retail Value Inc. Common Shares
RVI
| $906K | ﹤0.01% |
+302,309
| New | +$941K |
|
3670
PUT
Novartis
NVS
$287B
| $905K | ﹤0.01% |
11,718
-4,576
| -28% | -$338K |
|
3671
PUT
Tenet Healthcare
THC
$21.5B
| $905K | ﹤0.01% |
31,800
+6,100
| +24% | +$201K |
|
|
TRST
3672
Trustco Bank Corp NY
TRST
$976M
| $904K | ﹤0.01% |
21,295
+12,328
| +137% | +$557K |
|
3673
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.39B
| $900K | ﹤0.01% |
+33,363
| New | +$899K |
|
|
ARGO
3674
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $900K | ﹤0.01% |
14,283
+10,612
| +289% | +$654K |
|
|
SABA
3675
Saba Capital Income & Opportunities Fund II
SABA
$221M
| $898K | ﹤0.01% |
73,343
-169,791
| -70% | -$2.08M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.